Literature DB >> 4851738

Effects of degree of thrombocytopenia on thrombocytopoietic response.

T T Odell, J R Murphy.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4851738

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Early pregnancy in human may not be associated with mild thrombocytopenia.

Authors:  W S Yeung; Y F Chan; W K So; P C Ho; S T Chan
Journal:  J Assist Reprod Genet       Date:  1992-02       Impact factor: 3.412

Review 2.  Genome editing to define the function of risk loci and variants in rheumatic disease.

Authors:  Yuriy Baglaenko; Dana Macfarlane; Alexander Marson; Peter A Nigrovic; Soumya Raychaudhuri
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

3.  Massively parallel kinetic profiling of natural and engineered CRISPR nucleases.

Authors:  Stephen K Jones; John A Hawkins; Nicole V Johnson; Cheulhee Jung; Kuang Hu; James R Rybarski; Janice S Chen; Jennifer A Doudna; William H Press; Ilya J Finkelstein
Journal:  Nat Biotechnol       Date:  2020-09-07       Impact factor: 54.908

Review 4.  Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.

Authors:  Andrew V Anzalone; Luke W Koblan; David R Liu
Journal:  Nat Biotechnol       Date:  2020-06-22       Impact factor: 54.908

5.  How mathematical models can interpret and predict experimental results in haematology.

Authors:  H E Wichmann; R Gross
Journal:  Klin Wochenschr       Date:  1981-01-02

Review 6.  Significance of polyploidy in megakaryocytes and other cells in health and tumor disease.

Authors:  M Winkelmann; P Pfitzer; W Schneider
Journal:  Klin Wochenschr       Date:  1987-12-01

7.  Computational Approaches for Designing Highly Specific and Efficient sgRNAs.

Authors:  Jaspreet Kaur Dhanjal; Dhvani Vora; Navaneethan Radhakrishnan; Durai Sundar
Journal:  Methods Mol Biol       Date:  2022

8.  Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.

Authors:  John C Rose; Nicholas A Popp; Christopher D Richardson; Jason J Stephany; Julie Mathieu; Cindy T Wei; Jacob E Corn; Dustin J Maly; Douglas M Fowler
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

Review 9.  Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.

Authors:  Hongyi Li; Yang Yang; Weiqi Hong; Mengyuan Huang; Min Wu; Xia Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.